SK712003A3 - Process for the preparation of 4-(cyclopropylcarbonyl)-alpha, alpha-dimethylphenylacetic acid - Google Patents

Process for the preparation of 4-(cyclopropylcarbonyl)-alpha, alpha-dimethylphenylacetic acid Download PDF

Info

Publication number
SK712003A3
SK712003A3 SK71-2003A SK712003A SK712003A3 SK 712003 A3 SK712003 A3 SK 712003A3 SK 712003 A SK712003 A SK 712003A SK 712003 A3 SK712003 A3 SK 712003A3
Authority
SK
Slovakia
Prior art keywords
formula
mixture
cyclopropylcarbonyl
meta
alpha
Prior art date
Application number
SK71-2003A
Other languages
English (en)
Slovak (sk)
Inventor
Dandala Ramesh
Das Umashankar
Vela Venkata Naga Spriniva Div
Sunderam Sivakumaran Meenakshi
Original Assignee
Aurobindo Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aurobindo Pharma Ltd filed Critical Aurobindo Pharma Ltd
Publication of SK712003A3 publication Critical patent/SK712003A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42—Separation; Purification; Stabilisation; Use of additives
    • C07C51/43—Separation; Purification; Stabilisation; Use of additives by change of the physical state, e.g. crystallisation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pulmonology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK71-2003A 2001-06-25 2002-06-19 Process for the preparation of 4-(cyclopropylcarbonyl)-alpha, alpha-dimethylphenylacetic acid SK712003A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN511CH2001 2001-06-25
PCT/IN2002/000135 WO2003000658A1 (en) 2001-06-25 2002-06-19 PROCESS FOR THE PREPARATION OF A HIGHLY PURE PHARMACEUTICAL INTERMEDIATE, 4-(CYCLOPROPYLCARBONYL)-α,α-DIMETHYLPHENYLACETIC ACID

Publications (1)

Publication Number Publication Date
SK712003A3 true SK712003A3 (en) 2003-12-02

Family

ID=29765111

Family Applications (1)

Application Number Title Priority Date Filing Date
SK71-2003A SK712003A3 (en) 2001-06-25 2002-06-19 Process for the preparation of 4-(cyclopropylcarbonyl)-alpha, alpha-dimethylphenylacetic acid

Country Status (7)

Country Link
US (1) US6903232B2 (cg-RX-API-DMAC10.html)
EP (1) EP1401815A1 (cg-RX-API-DMAC10.html)
JP (1) JP2004521942A (cg-RX-API-DMAC10.html)
BG (1) BG107476A (cg-RX-API-DMAC10.html)
SI (1) SI21232A (cg-RX-API-DMAC10.html)
SK (1) SK712003A3 (cg-RX-API-DMAC10.html)
WO (1) WO2003000658A1 (cg-RX-API-DMAC10.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8168234B2 (en) * 2001-06-20 2012-05-01 Metaproteomics, Llc Compositions that treat or inhibit pathological conditions associated with inflammatory response
WO2003104197A1 (en) * 2002-06-10 2003-12-18 Teva Pharmaceutical Industries Ltd. Polymorphic form xvi of fexofenadine hydrochloride
DE102004031849A1 (de) 2004-06-30 2006-01-26 Sanofi-Aventis Deutschland Gmbh Verfahren zur Carbonylierung von Phenylalkylderivaten mit Kohlenmonoxid
WO2007007347A1 (en) * 2005-07-07 2007-01-18 Wockhardt Limited Industrial process of fexofenadine hydrochloride with controlled side products
CN102659667B (zh) * 2012-04-20 2013-08-14 浙江启明药业有限公司 一种非索非那定关键中间体的合成方法
ITMI20131652A1 (it) 2013-10-07 2015-04-08 Dipharma Francis Srl Procedimento per la purificazione di derivati dell'acido 2-fenil-2-metil-propanoico
RS59874B1 (sr) 2015-10-22 2020-03-31 Sanofi Aventis Deutschland Proces za pripremu feksofenadina i njegovih intermedijara

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020007068A1 (en) * 1999-07-16 2002-01-17 D'ambra Thomas E. Piperidine derivatives and process for their production
DK1026147T3 (da) * 1993-06-24 2004-03-22 Albany Molecular Res Inc Forbindelser, der er anvendelige som mellemprodukter i fremstillingen af piperidinderivater

Also Published As

Publication number Publication date
SI21232A (sl) 2003-12-31
EP1401815A1 (en) 2004-03-31
US6903232B2 (en) 2005-06-07
WO2003000658A1 (en) 2003-01-03
US20040077900A1 (en) 2004-04-22
BG107476A (bg) 2004-01-30
JP2004521942A (ja) 2004-07-22

Similar Documents

Publication Publication Date Title
KR100208867B1 (ko) 광학활성 퀴놀린메발론산의 디아스테레오머염
US4739101A (en) Method for the preparation of fibrates
EP1026147B1 (en) Compounds useful as intermediates in the production of piperidine derivatives
KR20000064387A (ko) 1-벤질-4-((5,6-디메톡시-1-인다논)-2-일)메틸피페리딘을제조하기위한방법및중간체
JP4344230B2 (ja) ピペリジン誘導体フェキソフェナジンの製造方法
US6903232B2 (en) Process for the preparation of a highly pure pharmaceutical intermediate, 4-(cyclopropylcarbonyl)-α, α-dimethylphenylacetic acid
US20100016601A1 (en) Process for preparing remifentanil, intermediates thereof, use of said intermediates and processes for the preparation thereof
AU2002320847A1 (en) Process for the production of the piperidine derivative fexofenadine
JP2004521942A5 (cg-RX-API-DMAC10.html)
US20020007068A1 (en) Piperidine derivatives and process for their production
US7446203B2 (en) Preparation of intermediates for acetycholinesterase inhibitors
US20090005567A1 (en) Process for the preparation of 4-(8-chloro-5,6-dihydro-11h-benzo (5,6)-cyclohepta-(1,2b) -pyridin-11-ylidene)-1-piperidinecarboxylic acid ethyl ester (loratadine)
KR101063146B1 (ko) 피타바스타틴 중간체의 제조방법 및 이를 이용한 피타바스타틴 헤미 칼슘염의 제조방법
US5112978A (en) Process for preparing alpha (alkyl phenyl)-4(hydroxy-diphenylmethyl)-1-piperidinyl butanol
JP3116051B2 (ja) 置換された3―アリール―3―カルボキシアルキルグルタルイミド、4―アリロ―4―シアノヘプタンジカルボン酸の環化によるこれらの製造方法、及び3―アリール―3―ヒドロキシアルキルピペリジンを製造するためのこれらの使用
WO2007135693A2 (en) Intermediates useful for the preparation of antihistaminic piperidine derivative
EP1992615B1 (en) A process for the preparation of keto compounds
US20020133013A1 (en) Process for making cyanomethyl ester precursors of flecainide
JP3255307B2 (ja) ジヒドロキシピペリジンジカルボキシレートの脱水法
KR20090035018A (ko) 펙소페나딘의 제조 방법
SU818483A3 (ru) Способ получени производных - 1-пипЕРидиНил - АлКил -АРил-КАРбОКСАМидА
WO2009136412A2 (en) PROCESS FOR PREPARATION OF 4-[4-(4-(HYDROXYDIPHENYLMETHYL)- 1-PIPERIDINYL]-1-OXOBUTYL]-α,α-DIMETHYLBENZENE ACETIC ACID METHYL ESTER AND USE THEREOF
EP2289867A2 (en) A process for producing 4-(4-halo-1-oxybutyl)-alpha,alpha-dimethylbenzene acetic acid or alkyl esters thereof
CN1414942A (zh) 2-苯基链烷酸衍生物的制备方法
FR2695637A1 (fr) Procédé de préparation de l'acide (E)-2-propyl pentène-2-oïque.